Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
41.6M
-
Shares change
-
+12.5M
-
Total reported value, excl. options
-
$919M
-
Value change
-
+$287M
-
Put/Call ratio
-
0.23
-
Number of buys
-
83
-
Number of sells
-
-47
-
Price
-
$22.30
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q1 2017
155 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q1 2017.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.6M shares
of 117M outstanding shares and own 35.6% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (5.06M shares), FMR LLC (4.53M shares), Pennant Capital Management, LLC (2.84M shares), VANGUARD GROUP INC (2.53M shares), Invesco Ltd. (2.27M shares), BLAIR WILLIAM & CO/IL (1.66M shares), PERCEPTIVE ADVISORS LLC (1.44M shares), MILLENNIUM MANAGEMENT LLC (1.4M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.31M shares), and TimesSquare Capital Management, LLC (1.31M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.